New balloon treatment aims to keep leg arteries open longer
NCT ID NCT07425171
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will test a special balloon coated with the drug paclitaxel to treat long blockages in the leg arteries. About 300 people with severe leg pain or wounds will receive the balloon treatment during a standard angioplasty procedure. Researchers will track how well the arteries stay open and whether patients need additional procedures over the next year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- paclitaxel-coated balloon
- What this could lead to
- If successful, this could provide a reliable treatment option for long blockages in leg arteries, reducing the need for repeat procedures and improving blood flow.
- What could go wrong
- This is an observational study, not a randomized trial, so results may be less definitive. The balloon uses a drug (paclitaxel) which has been linked to a small increased risk of death in some prior studies, though this is still debated.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FEMOROPOPLITEAL ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ajou University Hospital
Suwon, Gyeonggi-do, 16499, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.